Published in Ann Neurol on August 01, 1998
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16
Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging (2002) 3.34
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A (2005) 3.02
A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc (2001) 2.64
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci (2006) 2.34
LEAP: learning embeddings for atlas propagation. Neuroimage (2009) 2.09
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2006) 1.90
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain (2006) 1.86
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci (2008) 1.64
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging (2010) 1.63
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx (2005) 1.58
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage (2008) 1.49
Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study. Neuropsychology (2005) 1.48
Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord (2007) 1.46
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med (2006) 1.42
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology (2010) 1.41
Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis (2009) 1.40
APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol (2009) 1.37
Effect of parental family history of Alzheimer's disease on serial position profiles. Alzheimers Dement (2008) 1.32
Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx (2004) 1.30
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging (2000) 1.26
The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex (2011) 1.23
Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proc Natl Acad Sci U S A (2000) 1.22
Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS One (2012) 1.17
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease. Neuropsychol Rev (2007) 1.11
Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis (2011) 1.09
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
The apolipoprotein E gene, attention, and brain function. Neuropsychology (2002) 1.05
Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev (2003) 1.04
APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2014) 1.04
A review of the brain structure correlates of successful cognitive aging. J Neuropsychiatry Clin Neurosci (2011) 1.02
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults. Neurobiol Aging (2012) 1.00
Mapping the Alzheimer's brain with connectomics. Front Psychiatry (2012) 0.99
Hippocampal volumes are important predictors for memory function in elderly women. BMC Med Imaging (2009) 0.98
Children of persons with Alzheimer disease: what does the future hold? Alzheimer Dis Assoc Disord (2008) 0.97
Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. Neuroimage (2014) 0.97
Aerobic fitness relates to learning on a virtual Morris Water Task and hippocampal volume in adolescents. Behav Brain Res (2012) 0.96
Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp (2014) 0.96
Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging (2011) 0.94
Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease. Neuroimage (2009) 0.90
Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2012) 0.90
Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiol Aging (2008) 0.89
Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci (2014) 0.89
Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. J Prev Alzheimers Dis (2014) 0.88
Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imaging Behav (2014) 0.87
Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol (2001) 0.87
Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network. Radiology (2013) 0.86
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging (2015) 0.86
Mild cognitive impairment: historical development and summary of research. Dialogues Clin Neurosci (2004) 0.86
Current neuroimaging techniques in Alzheimer's disease and applications in animal models. Am J Nucl Med Mol Imaging (2012) 0.85
A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel. Med Image Anal (2015) 0.84
Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve. J Neurol Neurosurg Psychiatry (2005) 0.83
Asymmetries in the hippocampus and amygdala of chimpanzees (Pan troglodytes). Behav Neurosci (2004) 0.81
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia. Eur J Nucl Med Mol Imaging (2013) 0.80
Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype. J Neurol Neurosurg Psychiatry (2004) 0.80
White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. PLoS One (2012) 0.79
Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults. Am J Alzheimers Dis Other Demen (2013) 0.79
Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention? Front Aging Neurosci (2010) 0.78
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume. Neurobiol Aging (2016) 0.77
Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration. Psychopharmacology (Berl) (2006) 0.77
Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study. PLoS One (2016) 0.76
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism. Alzheimers Res Ther (2017) 0.76
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts. Brain Topogr (2014) 0.76
APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus. Front Hum Neurosci (2016) 0.75
Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning. Am J Alzheimers Dis Other Demen (2015) 0.75
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. Mayo Clin Proc (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37
Comparative genomics of the eukaryotes. Science (2000) 26.62
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05
Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet (1992) 15.62
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31
Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci (1999) 5.24
The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell (1994) 5.21
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell (1988) 4.34
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
A genetic linkage map of the mouse: current applications and future prospects. Science (1993) 4.24
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Changing patterns in surgical infections. Ann Surg (1973) 3.88
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell (1982) 3.86
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
The Genome Knowledgebase: a resource for biologists and bioinformaticists. Cold Spring Harb Symp Quant Biol (2003) 3.55
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med (2000) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet (1996) 3.28
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet (1997) 3.23
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
Thermosensory activation of insular cortex. Nat Neurosci (2000) 3.06
Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet (1994) 3.04
Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology (2004) 2.81
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging (2000) 2.80
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
Which atypical antipsychotic. Br J Psychiatry (1998) 2.67
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging (1997) 2.66
Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled trial. Thorax (2003) 2.63
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia (2007) 2.60
Waiting for medical services in Canada: lots of heat, but little light. CMAJ (2000) 2.56
Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.55
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (1997) 2.41
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum (2001) 2.37
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33
Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax (2008) 2.32
Doctor-patient interactions in oncology. Soc Sci Med (1996) 2.30
Hippocampal volume losses in minimally impaired elderly. Lancet (1995) 2.26
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology (2000) 2.25
Effect of satiation on brain activity in obese and lean women. Obes Res (2001) 2.25
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia (2010) 2.20
Palindrome resolution and recombination in the mammalian germ line. Mol Cell Biol (1997) 2.17
Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14
Severity prediction rules in community acquired pneumonia: a validation study. Thorax (2000) 2.14
COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind study. J Clin Rheumatol (2001) 2.09
Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ (1997) 2.09
DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes. Science (1985) 2.08
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther (2015) 2.08
Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry (1989) 2.07
The relationship between length of Barrett's oesophagus mucosa and body mass index. Aliment Pharmacol Ther (2014) 2.02
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study. BMJ (2008) 1.99
Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res (1998) 1.99
Proximity of the home to roads and the risk of wheeze in an Ethiopian population. Occup Environ Med (2005) 1.98
Neuroanatomical correlates of veridical and illusory recognition memory: evidence from positron emission tomography. Neuron (1996) 1.97
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96